Breaking News on Pharmaceutical Technology

Product news > QA/QC & validation

Latest news headlines

Products

Suppliers

US consent decree act aims to stop “regulatory frenzy”

07-Feb-2012 - A proposed US act aims to impose limitations on consent decrees and stop the “regulatory frenzy in Washington”.

Annual WHO meeting to tackle spread of substandard drugs

06-Feb-2012 - The WHO is urging countries to collaborate on tackling substandard drugs and strengthening supply chains at a new annual meeting.

FDA calls for more powers to adopt nationwide ePedigree

02-Feb-2012 - The US FDA has called for more authority to ensure any track-and-trace system is binding for industry and pre-empts state laws.

Pfizer recalls birth control pills after blister packaging error

01-Feb-2012 - Pfizer is recalling 28 lots of contraceptives after a blister packaging error raised the risk of unintended pregnancy.

Novartis hit with another 483 after FDA finds repeat failings

31-Jan-2012 - The FDA has hit Novartis with another 483 after finding seven repeat observations and a backlog of 1,360 overdue consumer complaints.

FDA updates Q&A to cut topical antiseptic contamination

30-Jan-2012 - The FDA has updated its question and answer document to help manufacturers of topical antiseptics prevent contamination.

Manufacturing issues round-up

26-Jan-2012 - in-PharmaTechnologist presents a round-up of issues within the pharmaceutical manufacturing industry, including Novartis’ plans to restart Nebraska ops and problems for Roche at it’s South Carolina facility.

US hits Ranbaxy with injunction to boost manufacturing quality

26-Jan-2012 - The US has filed a “groundbreaking” injunction against Ranbaxy to force the generic giant to make “fundamental changes” at its plants.

FDA & EMA plant approvals to cut bottlenecks at Genzyme

24-Jan-2012 - The FDA has followed the EMA in approving the Framingham, MA plant that Genzyme hopes will cut production bottlenecks.

Pharmacy aseptic failings likely cause of vision loss; researchers

23-Jan-2012 - Poor aseptic technique at compounding pharmacies is the most likely cause of Avastin-related vision loss, researchers claim.

SGS to open 2nd Indian lab on schedule; 2011 revs grow despite ‘tough’ European market

19-Jan-2012 - SGS’ new analytical lab in Mumbai, India will open later this week just six months after the analytical services firm began its construction .

FDA publishes QbD example to help generics firms file ANDAs

19-Jan-2012 - The FDA has published a QbD approach to modified release tablet development to help generic companies meet its 2013 deadline.

PIC/S adds GDP to remit to tackle supply chain threats

17-Jan-2012 - PIC/S has strengthened promotion of global GDP harmonisation and confidentiality in a revision to its documentation.

FDA plans to boost oversight using foreign regulators’ info

17-Jan-2012 - The US FDA plans to study foreign regulators’ GMP inspection reports with a view to using them to support its enforcement efforts.

FDA plans overseas inspections as GDUFA goes to Congress

16-Jan-2012 - The US FDA has sent its generic user fee recommendations to Congress ahead of a meeting to discuss the plan next month.

US team develops H-heterocyles production method with implications for Pharma

12-Jan-2012 - US scientists say a new N-heterocycles synthesis method could open door to the production of novel antibiotics, cancer and pain drugs.

Collaboration needed to reverse supply chain “neglect”; expert

11-Jan-2012 - Greater collaboration between regulators, suppliers and manufacturers is needed to reverse decades of supply chain neglect, an expert said.

Bumpy road ahead for Hospira but issues “fixable”, CEO says

11-Jan-2012 - Hospira will uncover more issues as it gets to the root cause of its quality troubles but the situation is “very fixable”, its CEO said.

US fake drug seizures up 200%

10-Jan-2012 - The value of counterfeit pharmaceuticals seized at US borders jumped 200 per cent in 2011 as enforcement actions took effect.

News in brief

India to inspect six China manufacturers following GMP complaints

09-Jan-2012 - Chinese companies exporting drugs in bulk will come under the microscope next month when the Indian government sends a team of officials to inspect manufacturing plants.

Novartis to take $120m charge to fix US plant, recall OTC drugs

09-Jan-2012 - Novartis expects to take a $120m charge to improve a US manufacturing plant and recall drugs after the FDA sent it a 483.

Accelrys moves into Pharma QA/QC with VelQuest acquisition

05-Jan-2012 - R&D software firm Accelrys says it will speed up the pharma QA/QC process and reduce the compliance risk ten-fold through its $35m takeover of VelQuest.

US FDA's 2011 guidance documents round-up

05-Jan-2012 - The US Food and Drug Administration (FDA) will soon start asking drugmakers to play a greater role in guideline development . Before that process begins in-Pharmatechnologist.com takes a look at the documents published by the agency in 2011.

FDA group calls for industry to submit draft guidance docs

04-Jan-2012 - The FDA should encourage industry to submit draft guidance to speed regulatory development, an agency working group found.

EC discusses ‘equivalence assessments’ for APIs shipped to EU

03-Jan-2012 - The European Commission (EC) has set out its plans for ‘equivalence assessments’ for manufacturers in countries seeking to export APIs to Europe.

Sign up for your free newsletter